Advertisement

Intra-arterial treatment of primary bone tumors

  • S. Wallace
  • C. H. Carrasco
  • C. Charnsangavej
  • W. Richli
  • N. Jaffe
  • J. Murray
  • A. Ayala
  • A. K. Raymond
  • S. P. Chawla
  • R. S. Benjamin

Abstract

Transcatheter intra-arterial infusion of chemotherapeutic agents for osteosarcomas and embolization of inoperable giant cell tumors of the axial skeleton have become essential components in patient management [1–13].

Keywords

Preoperative Chemotherapy Limb Salvage Giant Cell Tumor Giant Cell Tumor Lumbar Artery 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Akahoshi Y, Takeuchi S, Chen S et al (1976) The results of surgical treatment combined with intra-arterial infusion of anti-cancer agents in osteosarcoma. Clin Orthop 120: 103–109PubMedGoogle Scholar
  2. 2.
    Calvo DB, Patt YZ, Wallace S, Chuang VP, Benjamin RS, Pritchard JD, Hersh EM, Bodey GP, Mavligit GM (1980) Phase I trial of percutaneous intra-arterial (IA) cis-diamminedichloride-platinum II ( CDDP) for regionally confined malignancies. Cancer 45: 1278–1283PubMedCrossRefGoogle Scholar
  3. 3.
    Benjamin RS, Chuang VP, Wallace S et al (1982) Preoperative chemotherapy for osteosarcoma, abstract C-675. Am Soc Clin Oncol 1: 174Google Scholar
  4. 4.
    Jaffe N, Knapp J, Chuang VP et al (1983) Osteosarcoma: Intra-arterial treatment of the primary tumor with cis-diammine-dichloroplatinum II ( CDP ). Cancer 51: 402–407PubMedCrossRefGoogle Scholar
  5. 5.
    Benjamin RS, Murray JA, Wallace S et al (1984) Intra-arterial preoperative chemotherapy for osteosarcoma — a judicious approach to limb salvage. Cancer Bull 36: 32–36Google Scholar
  6. 6.
    Feldman F, Casarella WJ, Dick HM, Hollander BA (1975) Selective intraarterial embolization of bone tumors. Am J Roentgenol 123: 130–139Google Scholar
  7. 7.
    Dick HM, Bigliani LU, Michelsen WJ et al (1979) Adjuvant arterial embolization in the treatment of benign primary bone tumors in children. Clin Orthop 139: 133–141PubMedGoogle Scholar
  8. 8.
    Wallace S, Granmayeh M, de Santos LA et al (1979) Arterial occlusion of pelvic bone tumors. Cancer 43: 322–328PubMedCrossRefGoogle Scholar
  9. 9.
    Chuang VP, Soo CS, Wallace S, Benjamin RS (1981) Arterial occlusion: management of giant cell tumor and aneurysmal bone cyst. AJR 136: 1127–1130PubMedGoogle Scholar
  10. 10.
    Murphy WA, Strecker WB, Schoenecker PL (1982) Transcatheter embolization therapy of an ischial aneurysmal bone cyst. J Bone Joint Surg [Br] 64: 166–168Google Scholar
  11. 11.
    Eftekhari F, Wallace S, Chuang VP, Soo CS, Cangir A, Benjamin RS, Murray JA (1982) Intraarterial management of giant cell tumors of the spine in children. Pediatr Radiol 12: 289–293PubMedCrossRefGoogle Scholar
  12. 12.
    Channon GM, Williams LA (1982) Giant cell tumor of the ischium treated by embolization and resection: a case report. J Bone Joint Surg [Br] 64: 164–165Google Scholar
  13. 13.
    Keller FS, Rosch J, Bird CB (1983) Percutaneous embolization of bony pelvic neoplasms with tissue adhesive. Radiology 147: 21–27PubMedGoogle Scholar
  14. 14.
    Lichtenstein L (1972) Giant cell tumor of bone (osteoblastoma). In: Lichtenstein L (ed) Bone tumors. Mosby, St. Louis, pp 135–165Google Scholar
  15. 15.
    Dahlin DC (1978) Giant cell tumor (osteoclastoma). In: Dahlin DC (ed) Bone tumors. Thomas, Springfield, pp 99–115Google Scholar
  16. 16.
    Hilal SK, Michelsen JW (1975) Therapeutic percutaneous embolization for extraaxial vascular lesions of the head, neck and spine. J Neurosurg 43: 275–287PubMedCrossRefGoogle Scholar
  17. 17.
    Wallace S, Carrasco CH, Charnsangavej C, Lee YY, Wright K, Gianturco C (1984) Percutaneous transcatheter infusion and infarction in the treatment of human cancer: part II. Curr Probl Cancer 8: 5–76Google Scholar
  18. 18.
    Friedman MA, Carter SK (1972) The therapy of osteogenic sarcoma: current status and thoughts for the future. J Surg Oncol 4: 482–510PubMedCrossRefGoogle Scholar
  19. 19.
    Cade S (1955) Osteogenic sarcoma: a study based on 113 patients. J R Coll Surg Edinb 1: 79–111PubMedGoogle Scholar
  20. 20.
    Lee ES, Mackenzie DH (1964) Osteosarcoma: a study of the value of preoperative megavoltage radiotherapy. Br J Surg 51: 252–274PubMedCrossRefGoogle Scholar
  21. 21.
    Jenkin RDT, Allt WEC, Fritzpatrick PJ (1972) Osteosarcoma: an assessment of management with particular reference to primary irradiation and selective delayed amputation. Cancer 30: 393–400PubMedCrossRefGoogle Scholar
  22. 22.
    Marcove RC, Mike V, Hajek JV et al (1971) Osteogenic sarcoma in childhood. NY State J Med 71: 855–859Google Scholar
  23. 23.
    Jeffree CM, Price CHG, Sessons HA (1975) The metastatic patterns of osteosarcoma. Br J Cancer 32: 87–107PubMedCrossRefGoogle Scholar
  24. 24.
    Greesbeck HP, Cudmore JTP (1963) Evaluation of 5-fluorouracil (5-FU) in surgical practice. Am Surg 29: 638–641Google Scholar
  25. 25.
    Sullivan MP, Sutow WW, Taylor G (1963) L-phenylalanine mustard as treatment for osteogenic sarcoma in children. J Pediatr 63: 227–237PubMedCrossRefGoogle Scholar
  26. 26.
    Finkelstein J, Hittle RE, Hammond UD (1969) Evaluation of high dose cyclophosphamide regimen in childhood tumors. Cancer 23: 1239–1244CrossRefGoogle Scholar
  27. 27.
    Sutow WW (1976) Evaluation of dosage schedules of mitomycin C (NSC-26980) in children. Cancer Chemother Rep 55: 285–289Google Scholar
  28. 28.
    Jaffe N (1976) Osteogenic sarcoma: state of the art with high-dose methotrexate treatment. Clin Orthop 120: 95–102PubMedGoogle Scholar
  29. 29.
    Jaffe N, Link M, Traggis D etal (1981) The role of high-dose methotrexate in osteogenic sarcoma: sarcomas of soft tissue and bone in childhood. Natl Cancer Inst Monogr 56: 2101–2106Google Scholar
  30. 30.
    Cortes EP, Holland JF, Wang JJ etal (1974) Amputation and adriamycin in primary osteosarcoma. N Engl J Med 291: 998–1000PubMedCrossRefGoogle Scholar
  31. 31.
    Ochs JJ, Freeman AI, Douglass HO et al (1978) Cis-dichloro-diammineplatinum ( II) in advanced osteogenic sarcoma. Cancer Treat Rep 62: 239–245Google Scholar
  32. 32.
    Pinkel D (1969) Cyclophosphamide in children with cancer. Cancer 15: 42–49CrossRefGoogle Scholar
  33. 33.
    Cortes EP, Necheles TF, Holland JF et al (1979) Adrimycin (ADR) alone versus ADR and high dose methotrexate-citrovorum factor rescue (HDM-CFR) as adjuvant to operable primary osteosarcoma: a randomized study by Cancer and Leukemia Group B ( CALGB ). Proc Am Assoc Cancer Res 20: 412Google Scholar
  34. 34.
    Sutow WW, Sullivan MP, Wilbur JR et al (1975) A study of adjuvant chemotherapy in osteogenic sarcoma. J Clin Pharmacol 7: 530–533Google Scholar
  35. 35.
    Jaffe N, Watts N, Fellows KE et al (1978) Local en bloc resection for limb preservation. Cancer Treat Rep 62: 217–223PubMedGoogle Scholar
  36. 36.
    Rosen G, Marcove RC, Caparros B et al (1979) Primary osteogenic sarcoma: The rationale for preoperative chemotherapy and delayed surgery. Cancer 43: 2163–2177PubMedCrossRefGoogle Scholar
  37. 37.
    Morton DL, Eilber FR, Townsend CN Jr et al (1976) Limb salvage from a multidisciplinary treatment approach for skeletal and soft tissue sarcomas of the extremity. Ann Surg 184: 268–278PubMedCrossRefGoogle Scholar
  38. 38.
    Rosen G, Murphy ML, Huvos AG et al (1976) Chemotherapy, en bloc resection and prosthetic bone replacement in the treatment of osteogenic sarcoma. Cancer 37: 1–11PubMedCrossRefGoogle Scholar
  39. 39.
    Marcove RC (1977) En bloc resection for osteogenic sarcoma. Can J Surg 20: 521–528PubMedGoogle Scholar
  40. 40.
    Huvos AG, Rosen G, Marcove RC (1977) Primary osteogenic sarcoma: Pathologic aspects in 20 patients after treatment with chemotherapy, en bloc resection and prosthetic bone replacement. Arch Pathol Lab Med 101: 14–18PubMedGoogle Scholar
  41. 41.
    Rosen G, Caparros B, Huvos A et al (1982) Preoperative chemotherapy for osteogenic osteosarcoma: Selection of postoperative adjuvant chemotherapy based on the response of the primary tumor to preoperative chemotherapy. Cancer 49: 1221–1230PubMedCrossRefGoogle Scholar
  42. 42.
    Eilber FR, Grant T, Morton DL (1978) Adjuvant therapy for osteosarcoma: Pre-operative treatment. Cancer Treat Rep 62: 213–216PubMedGoogle Scholar
  43. 43.
    Jaffe N, Prudich J, Knapp J et al (1981) Osteosarcoma: treatment of the primary tumor with intra-arterial high-dose methotrexate (MTX-CF): pharmcokinetic, clinical, radiographic and pathologic studies. Abstract C-409. Proc Am Assoc Cancer Res 22: 195Google Scholar
  44. 44.
    Rosen G, Marcove RC, Huvos AG et al (1983) Primary osteogenic sarcoma: Eight-year experience with adjuvant chemotherapy. J Cancer Res Clin Oncol 106 [Suppl]: 55–67PubMedCrossRefGoogle Scholar
  45. 45.
    Jaffe N, Bowman R, Wang Y-M et al (1984) Chemotherapy for primary osteosarcoma by intra-arterial infusion: review of the literature and comparison with results achieved by the intravenous route. Cancer Bull 36: 37–42Google Scholar
  46. 46.
    Nitsche R, Starling KA, Vats T et al (1978) Cis-diammine-dichloroplatinum (NSC-119875) in childhood malignancies: a Southwest Oncology Group study. Med Pediatr Oncol 4: 127–132CrossRefGoogle Scholar
  47. 47.
    Baum F, Greenberg L, Gaynon P et al (1978) Use of cis-platinum diammine dichloride (CPDD) in osteogenic sarcoma ( OS) in children. Proc Am Assoc Cancer Res 19: 385Google Scholar
  48. 48.
    Freeman AI, Ettinger LJ, Brecher ML (1979) Cis-dichloro-diammineplatinum II in childhood cancer. Cancer Treat Rep 63: 1615–1620PubMedGoogle Scholar
  49. 49.
    Pratt CB, Hayes A, Green AA et al (1981) Pharmacokinetic evaluation of cisplatin in children with malignant solid tumors: a phase II study. Cancer Treat Rep 65: 1021–1026PubMedGoogle Scholar
  50. 50.
    Rosen G, Nirenberg H, Caparros B et al (1980) Cisplatin in metastatic osteogenic sarcoma. In: Prestayko AW, Crooke ST, Carter SK (eds) Cisplatin: current status and new developments. Academic Press, New York, pp 465–475Google Scholar
  51. 51.
    Ettinger LJ, Douglass HO Jr, Higby IJ et al (1981) Adjuvant adriamycin and cis-diammine-dichloroplatinum (cis-platinum) im primary osteosarcoma. Cancer 47: 248–254PubMedCrossRefGoogle Scholar
  52. 52.
    Baum ES, Gaynon P, Greenberg L et al (1981) Phase II trial of cisplatin in refractory childhood cancer: Children’s Cancer Study Group report. Cancer Treat Rep 65: 815–822PubMedGoogle Scholar
  53. 53.
    Rosen G, Caparros B, Nirenberg A et al (1982) Cisplatinum (DDP)-adriamycin (ADR) combination chemotherapy (CT) in evaluable osteogenic sarcoma (OS), abstract C-672. Am Soc Clin Oncol 1: 173Google Scholar
  54. 54.
    Carrasco CH, Charnsangavej C, Raymond AK, Richli WR, Wallace S, Chawla SP, Ayala AG, Murray JA, Benjamin RS (1987) Angiographie assessment of response to preoperative chemotherapy in osteosarcoma. Radiology (in press)Google Scholar
  55. 55.
    Wright KC, Wallace S, Kim EE, Haynie T, Charnsangavej C, Carrasco C, Chuang VP, Gianturco C (1986) Pulsed arterial infusions. Chemotherapeutic implications. Cancer 57: 1952–1956PubMedCrossRefGoogle Scholar
  56. 56.
    Chuang VP, Benjamin RS, Jaffe N, Wallace S, Ayala AG, Murray J, Charnsangavej C, Soo CS (1982) Radiographic and angiographic changes in osteosarcoma after intraarterial chemotherapy. AJR 139: 1065–1069PubMedGoogle Scholar
  57. 57.
    Ayala A, Raymond AK, Jaffe N (1984) The pathologist’s role in the diagnosis and treatment of osteosarcoma in children. Human Pathol 15: 258–266CrossRefGoogle Scholar

Copyright information

© Springer-Verlag/Wien 1988

Authors and Affiliations

  • S. Wallace
    • 1
  • C. H. Carrasco
    • 1
  • C. Charnsangavej
    • 1
  • W. Richli
    • 1
  • N. Jaffe
    • 2
  • J. Murray
    • 3
  • A. Ayala
    • 4
  • A. K. Raymond
    • 4
  • S. P. Chawla
    • 5
  • R. S. Benjamin
    • 5
  1. 1.Department of Diagnostic RadiologyThe University of Texas System Cancer Center M. D. Anderson Hospital and Tumor InstituteHoustonUSA
  2. 2.Department of PediatricsThe University of Texas System Cancer Center M. D. Anderson Hospital and Tumor InstituteHoustonUSA
  3. 3.Department of General SurgeryThe University of Texas System Cancer Center M. D. Anderson Hospital and Tumor InstituteHoustonUSA
  4. 4.Department of Anatomical PathologyThe University of Texas System Cancer Center M. D. Anderson Hospital and Tumor InstituteHoustonUSA
  5. 5.Department of Medical OncologyThe University of Texas System Cancer Center M. D. Anderson Hospital and Tumor InstituteHoustonUSA

Personalised recommendations